Efficacy and safety of dihydroartemisinin-piperaquin (2007)
by Academia Educational
Submitted by
C
Cwuka 
410c 7.09
Ranked
Efficacy and safety of dihydroartemisinin-piperaquin
by H.Y. Myint , E.A. Ashley , N.P.J. Day , F. Nosten , N.J. White
Dihydroartemisinin-piperaquine, a fixed-dose combination antimalarial, is an inexpensive, safe and highly effective treatment for uncomplicated falciparum or vivax malaria. Efficacy assessed over 28-63 days has consistently exceeded 95% in the treatment of multidrug-resistant falciparum malaria. More than 2600 patients have been treated with this combination in prospective studies, mainly in Southeast Asia.🏁
Submitted by Cwuka - 05/01/2026
Academia Educational 7.09 Ranked
Global Leaderboard
| # | Player | Time | Duration | Accuracy | WPM | pp | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ||||||||
| 2 | ||||||||
| 3 | ||||||||
| 4 | ||||||||
| 5 | ||||||||
| 6 | ||||||||
| 7 | ||||||||
| 8 | ||||||||
| 9 | ||||||||
| 10 |
Efficacy and safety of dihydroartemisinin-piperaquin
by H.Y. Myint , E.A. Ashley , N.P.J. Day , F. Nosten , N.J. White
Dihydroartemisinin-piperaquine, a fixed-dose combination antimalarial, is an inexpensive, safe and highly effective treatment for uncomplicated falciparum or vivax malaria. Efficacy assessed over 28-63 days has consistently exceeded 95% in the treatment of multidrug-resistant falciparum malaria. More than 2600 patients have been treated with this combination in prospective studies, mainly in Southeast Asia.🏁
Submitted by Cwuka - 05/01/2026
Academia Educational 7.09 Ranked